Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors. It filed for Chapter 7 bankruptcy on July 5, 2012. [1]

Jul 9, 2012 · Biolex Therapeutics is calling it quits after burning through $190 million of venture cash from a slate of top-tier biopharma players on a once-promising hepatitis C drug.

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency.

The LEX System gives Biolex the ability to develop a therapeutic protein from the primary amino acid sequence through a scale-up of purified cGMP product suitable for clinical trials and commercial supply. The system couples the natural characteristics of Lemna with advanced genetic engineering and protein recovery methods.

Jan 7, 2025 · Learn about Biolex uses, dosage, side effects, food interactions, and more. Get all the details about Biolex from MedicinesFAQ.

A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee

Dr. David J. Bearss is a trendsetting entrepreneur of drug development with over 20 years’ of experience. Not only is David an industry-leading expert in small molecule drug development and genetic model systems for drug discovery, but he also has unique experience in translational research focused on the use of genetic markers to predict drug sensitivity.

Biolex is a clinical-stage biopharmaceutical company that uses its patented LEX System(SM) to develop hard-to-make therapeutic proteins and to optimize monoclonal antibodies. The LEX System is a novel technology that genetically transforms the aquatic plant Lemna to enable the production of biologic product candidates.

Feb 27, 2025 · Biolex® MB40 represents a scientifically validated prebiotic supplement for supporting canine digestive health through multiple complementary mechanisms. Its premium composition of brewers’ yeast cell walls provides naturally high levels of mannan-oligosaccharides and β-glucans that selectively enhance beneficial microbes, optimise short ...

And since 1998, Pittsboro, North Carolina-based Biolex, Inc. has been taking this technology into a new arena: plant-based production of hard-to-make proteins, such as peptides, cytokines, plasma proteins, monoclonal antibodies, and other therapeutic proteins for human health.